Skip to content

Lifestyle Intervention to Improve Muscle Function in Older Adults

Lifestyle Intervention to Improve Muscle Function in Older Adults

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07597980
Enrollment
80
Registered
2026-05-20
Start date
2026-07-20
Completion date
2030-12-01
Last updated
2026-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body Composition, Energy Balance, Physical Function

Keywords

Fat mass, muscle mass, physical function, energy deficit

Brief summary

The goal of this randomized controlled two-arm trial is to determine the effect of a diet and exercise intervention for 12 weeks on body composition, muscle function, and energy balance in 80 adults aged 50 years and over with obesity and insulin resistance. The main questions the trial aims to answer are: Will 12 weeks of a structured nutrition plan + exercise reduce fat mass, improve muscle function, and increase energy deficit compared to the usual diet + exercise. The hypothesis is that 12 weeks of a structured nutrition plan + exercise will reduce fat mass, improve muscle function, and produce greater energy deficit than the usual diet + exercise. Participants will be provided with all meals for 12 weeks and will exercise at the Center under supervision three times each week. Pre and post-intervention, body composition, physical function, and energy deficit will be measured.

Detailed description

In the United States nearly one third of adults over 60 years of age have sarcopenic obesity which encompasses the combined effect of muscle impairment and obesity. A strategy that addresses the combined effect of muscle impairment and obesity while modulating muscle mass and composition is an unanswered challenge. This 12-week study will evaluate the effects of a structured nutrition plan combined with an exercise program on body fat and muscle mass, lower-extremity function (Short Physical Performance Battery), muscle strength (handgrip and knee strength), and daily caloric intake. The study will enroll adults aged 50 years and older with obesity (body mass index ≥ 30 kg/m²) and insulin resistance as indicated by a homeostasis model assessment of insulin resistance (HOMA-IR) score ≥ 3. Subjects will be randomly allocated to receive the structured nutrition plan and exercise intervention or to their usual diet and exercise in equal numbers (40 per group). The study will enrich our understanding of the physiological adaptations necessary for effective lifestyle interventions to improve muscle function.

Interventions

BEHAVIORALStructured nutrition plan

Participants will receive a structured nutrition plan.

BEHAVIORALTypical or usual diet

Participants will receive a diet representing the usual diet in this population.

BEHAVIORALSupervised Exercise

Participants will complete aerobic and resistance training under supervision three times per week.

Sponsors

Pennington Biomedical Research Center
Lead SponsorOTHER
National Institute on Aging (NIA)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age \> 50 years. 2. Body mass index (BMI) ≥ 30 kg/m2. 3. Homeostatic model assessment of insulin resistance ≥ 3. 4. Mini-Mental State Examination (MMSE) \> 25. 5. Geriatric Depression Scale-15 (GDS-15) \< 9. 6. Sedentary (less than 90 minutes/week of moderate to vigorous activity). 7. Ability to provide written informed consent.

Exclusion criteria

1. Diagnosis of cancer (received within five years) or diabetes (type 1 and 2), or significant musculoskeletal, or cardiovascular, or hepatic, or renal, disease or dysfunction. 2. Clinically significant gastrointestinal malabsorption syndromes such as chronic diarrhea, celiac disease, or clinically significant abnormal laboratory markers. 3. Fluctuation in body weight \> 3 kg in the preceding two months 4. Condition that impedes testing of the study hypothesis or makes it unsafe to exercise or consume the study foods.

Design outcomes

Primary

MeasureTime frameDescription
Fat massChange from baseline to 12 weeksFat mass measured by dual X-ray absorptiometry

Secondary

MeasureTime frameDescription
Skeletal muscle massChange in from baseline to 12 weeksSkeletal muscle mass will be measured by the creatine methyl D-3 dilution method
Short physical performance batteryChange from baseline to 12 weeksA test of physical function
Hand-grip strengthChange from baseline to 12 weeksHand grip strength will be measured using a hand dynamometer
Knee strengthChange from baseline to12 weeksKnee strength will be measured quantified using Biodex dynamometry
Energy stores12 weeksChange in energy stores/day (kcal) determined from measures of body composition using the energy balance method
Hormonal regulation of energy balanceChange from baseline to 12 weeksBlood concentrations of glucagon-like peptide 1
Cardiorespiratory fitnessChange in VO2max from baseline to 12 weeksVO2max

Countries

United States

Contacts

CONTACTCandida J Rebello, PhD, RD
Candida.Rebello@pbrc.edu12257633159
CONTACTReilly Roberts A Project Manager, MS
candidajoan@hotmail.com225-763-2854
PRINCIPAL_INVESTIGATORCandida J Rebello, PhD, RD

Pennington Biomedical Research Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 4, 2026